OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.040
0.00 (0.00%)
Jan 17, 2025, 4:00 PM EST - Market closed
OKYO Pharma Employees
OKYO Pharma had 3 employees as of March 31, 2024. The number of employees decreased by 5 or -62.50% compared to the previous year.
Employees
3
Change (1Y)
-5
Growth (1Y)
-62.50%
Revenue / Employee
n/a
Profits / Employee
-$5,608,487
Market Cap
35.19M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
OKYO News
- 2 months ago - MUSQ Global Music Industry ETF and OKYO Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 3 months ago - OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain - GlobeNewsWire
- 5 months ago - OKYO Pharma and SolarMax Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 5 months ago - OKYO Pharma CEO Interview to Air on Bloomberg TV - GlobeNewsWire
- 5 months ago - OKYO Pharma Announces Chairman Acquires Shares - GlobeNewsWire
- 5 months ago - OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - GlobeNewsWire
- 5 months ago - OKYO Pharma Granted European Patent Covering OK-101 Chemerin Analogs and Their Method of Use - GlobeNewsWire
- 6 months ago - OKYO Pharma to Initiate Neuropathic Corneal Pain Trial for OK-101 - GlobeNewsWire